![Xi Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xi Yu
Direktor/Vorstandsmitglied bei
QYUNS THERAPEUTICS CO., LTD.
Profil
Xi Yu is currently a Non-Executive Director at Qyuns Therapeutics Co., Ltd. He previously worked as a Director of Business Strategy & Development at Xian Janssen Pharmaceutical Ltd. and as a Director of Business Development at Sanofi-Aventis China Investment Co. Ltd. Mr. Yu completed his undergraduate degree at East China University of Science & Technology in 1997.
Aktive Positionen von Xi Yu
| Unternehmen | Position | Beginn |
|---|---|---|
| QYUNS THERAPEUTICS CO., LTD. | Direktor/Vorstandsmitglied | 14.08.2020 |
Ehemalige bekannte Positionen von Xi Yu
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi-Aventis China Investment Co. Ltd. | Corporate Officer/Principal | - |
Xian Janssen Pharmaceutical Ltd.
 Xian Janssen Pharmaceutical Ltd. BiotechnologyHealth Technology Engages in developing, introducing and producing drugs & innovative medical solutions | Corporate Officer/Principal | - |
Ausbildung von Xi Yu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xian Janssen Pharmaceutical Ltd.
Xian Janssen Pharmaceutical Ltd. BiotechnologyHealth Technology Engages in developing, introducing and producing drugs & innovative medical solutions | Health Technology |
Qyuns Therapeutics Co., Ltd.
 Qyuns Therapeutics Co., Ltd. BiotechnologyHealth Technology Engages in research and development, manufacturing & sale of biologic therapies for autoimmune and allergic diseases | Health Technology |
Sanofi-Aventis China Investment Co. Ltd. |
